Elanco Animal Health Inc Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Elanco Animal Health Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2018 to Q3 2024.
  • Elanco Animal Health Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 498M shares, a 1.02% increase year-over-year.
  • Elanco Animal Health Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 492M shares, a 0.82% increase from 2022.
  • Elanco Animal Health Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 488M shares, a 0.23% increase from 2021.
  • Elanco Animal Health Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 487M shares, a 10.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 498M +5M +1.02% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 494M +1.6M +0.33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 496M +3.2M +0.65% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 492M +4M +0.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 493M +4.3M +0.88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 493M +4.2M +0.86% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 493M +600K +0.12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 488M +900K +0.19% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 488M +1.1M +0.23% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 488M +1.1M +0.23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 492M +5.5M +1.13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 487M +46M +10.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 487M +24.9M +5.39% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-01
Q2 2021 487M +74.1M +17.9% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 487M +82.8M +20.5% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q4 2020 441M +71.1M +19.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 462M +89.2M +23.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 413M +46.2M +12.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 404M +37.9M +10.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 370M +56.6M +18% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 373M +72M +23.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 367M +73.7M +25.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 366M +72.7M +24.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 314M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 301M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 293M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 293M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.